Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

VERAPAMIL HYDROCHLORID

Active

SPE2DP-26-T-4217Federal

Response Deadline07/27/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

5250 GIBSON AVE BLDG 5250, JBER, AK, 99506-4400, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation

PostedJul 21

Solicitation

Response DeadlineJul 27

Submission deadline

Response Deadline

07/27/2026, 05:00:00 PM UTCin 5 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressUS

Contacts

DANIEL PORTER

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

VERAPAMIL HYDROCHLORIDE INJECTION
VERAPAMIL HYDROCHLORIDE INJECTION
.
VERAPAMIL HYDROCHLORIDE INJECTION 5 MG/2 ML (2.5 MG/ML) 2ML SINGLE-DOSE
GLASS FLIPTOP VIAL 25S. PRESERVATIVE FREE. PROTECT FROM LIGHT. FOR
INTRAVENOUS USE ONLY. STORE AT 20 TO 25 C (68 TO 77F). SEE USP
CONTROLLED ROOM TEMPERATURE.
.
UNIT OF ISSUE PACKAGE(PG) OF 25 EACH
.
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
. SHALL HAVE A SHELF LIFE OF 24 MONTHS. NOT MORE THAN 4 MONTHS SHALL HAVE ELAPSED FROM THE DATE OF MANUFACTURE TO THE DATE OF DELIVERY TO THE GOVERNMENT. . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
ADEQUATE DATA FOR THE NSN/Part Number: 6505-01-738-0226 Quantity: 1 PG Purchase Request: 7017548722QTY: 1 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

PSYLLIUM HYDROPHILIC MThe contract is for Psyllium Hydrophilic Mucilloid in sugar orange flavor, supplied in 12 gm packets, with each packet containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per box. The item is regulated by the FDA and must be procured with the specified manufacturer part number NDC37000-0740-87 from The Procter & Gamble Distributing LLC. It carries a non-extendable 24-month shelf life under Type I (Code M) requirements and must be packaged and marked in strict accordance with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet DLA requirements, including commercial-grade sealed unit containers and shipping containers that ensure safe delivery at the lowest possible rate. The unit of issue is a package of 30s, with a total quantity of 4 packages required. Delivery is FOB destination within 20 days, with zero variance permitted, and inspection and acceptance occur at the delivery point. The shipment is designated for a military vessel, with specific transportation protocols requiring the use of traceable methods and prohibiting parcel post. All labeling, packing, and marking must comply with applicable DLA standards, and bidders must clearly state the source and part number. The contract is issued under solicitation SPE2DP-26-T-4220 with an original delivery deadline of July 23, 2026, and is managed by the Department of Defense’s Medical Supply Chain PHARM FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

SUMATRIPTAN SUCCINATE

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

Pharmaceutical Repackaging and Labeling ServicesThe contract involves the repackaging of fluconazole tablets into containers that meet Department of Defense compliance standards, ensuring proper military-specific labeling with National Stock Number, Technical Control Number, and military identification blocks. This work requires strict adherence to DoD packaging and labeling protocols to ensure accurate traceability, inventory control, and field distribution within military supply chains. The contractor must handle pharmaceuticals under appropriate conditions to maintain product integrity and regulatory compliance throughout the repackaging process. The performance of this subcontract falls under NAICS code 325411 for pharmaceutical and medicine manufacturing and is managed by the Defense Logistics Agency on behalf of the Department of Defense. While specific location details for performance or contact information are not provided, the contract is tied to a defined delivery and award mechanism through DLA’s procurement system, indicating it supports routine military pharmaceutical supply needs. The work is scheduled to be active following a public posting in July 2026, and the nature of the task suggests the contractor must possess experience in regulated pharmaceutical repackaging and familiarity with military logistical requirements.

Defense Logistics Agency

POSTED

DEADLINE

SODIUM CHLORIDE INJECTSodium Chloride Injection is a sterile, nonpyrogenic intravenous solution designated for fluid and electrolyte replenishment, serving as a source of water and essential electrolytes. It contains no antimicrobial agents and is supplied in single-dose containers, intended for medical use under strict aseptic conditions. The product must comply with stringent packaging and marking requirements per Medical Marking Standard No. 1, superseding MIL-STD-129, and must be labeled in accordance with SPE2DP-26-T-4198. Each unit must be sealed in protective packaging to prevent damage or breakage and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate to the delivery point. The product must be stored in moisture barrier overwrap at room temperature (25°C/77°F), avoiding excessive heat, and must maintain a shelf life of 15 months with no more than two months elapsed between manufacture and government delivery. It is manufactured by Baxter Healthcare Corporation under part number 2B1313Q and identified by NSN 6505014622120, with a unit of issue of PG. The contract specifies a single unit quantity of one PG to be delivered within 20 days FOB destination, with zero variance permitted in quantity and inspection and acceptance occurring at the point of delivery. The solicitation under number SPE2DP-26-T-4198, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, requires compliance with the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition size. The product must be procured under the DoD authorized unit of issue, referenced via official DLA documentation. All documentation, including marking and packaging, must strictly adhere to current DLA standards, and technical specifications are incorporated by reference. The point of contact is Meghan Smink, with the place of performance identified as Sea Girt, NJ, 08750-0000, and the response deadline for bids closing in July 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SKIN PROTECTIVE OINThe contract specifies the procurement of 3M CAVILON DURABLE BARRIER CREAM 3355, a concentrated, pH-balanced, waterproof skin protective ointment formulated with 3M polymer technology to resist wash-off and enhance adhesive adherence while moisturizing skin and safeguarding against bodily fluids. Each unit is a 3.25-ounce (92 g) tube, sold in a case of twelve, and must be stored at room temperature between 68°F and 77°F (20°C to 25°C), with temporary excursions allowed between 59°F and 86°F (15°C to 30°C). The product has a non-extendable shelf life of 24 months under the RS016 requirement for a Type I code M item. The specification incorporates technical and quality standards from the DLA Master List of Technical and Quality Requirements, with compliance tied to the master list revision effective on the solicitation or award date. Packaging must meet DLA procurement standards, and government identification must be removed from non-accepted supplies. Covered defense information may apply, and bidders are required to clearly state the source and part number being supplied. The NSN is 6505-01-727-6854, with a single case order quantity under purchase request 7017546881, and delivery is required within 20 days of order award. The solicitation, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, has a response deadline of July 27, 2026, and is cataloged under NAICS code 325411 with performance at Nellis AFB, Nevada.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Radioactive or Special-Marking MaterialsThe contract pertains to the supply or handling of materials requiring specialized labeling, including those with radioactive properties, and mandates strict adherence to MIL-STD-129 standards for marking and packaging. Compliance with advance notification protocols is required to ensure proper tracking, safety, and regulatory alignment throughout the logistics chain. The work is classified as a subcontract under NAICS code 325411 and is managed by the ACTIVE DEVICES DIVISION of the Department of Defense, with performance exclusively located at Robins Air Force Base, Georgia, zip code 31098-1887. Interested parties must respond by the deadline of July 30, 2026, with solicitation details accessible via the provided DIBBS link. The contract emphasizes stringent operational controls for hazardous or specially marked items, requiring suppliers to demonstrate proven capability in handling sensitive materials under federal defense protocols. No set-aside designation is specified, and the procurement is open to qualified subcontractors capable of meeting the technical and compliance demands tied to military-grade material handling.

ACTIVE DEVICES DIVISION

POSTED

DEADLINE

REHYDRATION SALTS FORThe contract is for the procurement of 2 packages of orange-flavored electrolyte oral rehydration salts, each package containing 100 units of 21-gram sachets, under NSN 6505-01-687-1441 and part number 61410, supplied by Drip Drop Hydration Inc. The item is classified as a Type I (Code Q) medical product with a mandatory non-extendable shelf life of 36 months, and all packaging and labeling must strictly comply with Medical Marking Standard No. 1, superseding MIL-STD-129. Packaging must be commercial-grade, sealed to prevent damage or breakage, and shipped in exterior containers suitable for safe transport at the lowest freight rate to the destination, adhering to DLA’s packaging requirements and ASTM D3951 unless federal standards take precedence. The product is not classified as hazardous under FED-STD-313 and must be palletized per RP001. Delivery is FOB destination within 20 days of contract award, with no quantity variance permitted, and inspection and acceptance occur at the delivery point. The shipment is destined for the USS GETTYSBURG CG 64 at FPO AA 34091, with transportation governed by DLA procedural notes C19 and C20. The contract, issued under solicitation SPE2DP-26-T-4190, requires compliance with all technical and quality requirements from the DLA Master List, and the original required delivery date is July 20, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DOCOSANOL CREAMThe contract solicitation SPE2DP-26-T-4191 is for the procurement of DOCOSANOL CREAM 10% in 2g tubes, an FDA-regulated topical treatment for herpes simplex virus type 1 (HSV-1), commonly used to shorten healing time and soothe symptoms of cold sores or fever blisters on the face or lips for adults and children 12 years of age and older. The product must be stored between 20°C and 25°C (68°F to 77°F) and must not be frozen, with a non-extendable shelf life of 24 months classified as a TYPE I (CODE M) item. Deliveries are required to be made within 20 days of order receipt, with specified delivery dates ranging from April to May 2026, and are to be delivered FOB destination to multiple U.S. military installations including Fort Carson, Colorado and Fort Bragg, North Carolina. The entire order consists of 28,000 tubes distributed across five contract line item numbers (CLINs), with each CLIN specifying precise bulk break points and delivery addresses for government receipt. All items must be packaged in accordance with MIL-STD-2073-1E using commercial-grade methods that ensure protection against damage during transit, and must be palletized per DLA Packaging Requirements (RP001). Marking must strictly follow Medical Marking Standard No. 1, which supersedes MIL-STD-129 for all medical acquisitions, and includes barcode and labeling requirements accessible through DLA Troop Support. Shipment must be traceable through common carriers—parcel post is prohibited—and invoicing must be processed via the Wide Area WorkFlow system. The item is regulated under the FDA, and contractors must comply with applicable FAR and DFARS clauses, including cybersecurity safeguards (252.204-7012), prohibitions on restricted telecommunications equipment (252.204-7018), requirements for whistleblower protections (252.203-7002), and ethical restrictions on former DoD officials. Offerors must provide a Unique Entity Identifier and CAGE code, affirm size status and socioeconomic certifications where applicable, and comply with all representation and certification requirements in Section K. Technical and quality requirements referenced by R, I, or other identifiers are governed by the DLA Master List of Technical and Quality Requirements, and any

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacturer Sourcing for NDC-Specified ItemsThe contract authorizes the supply of surgical detergent exclusively from manufacturers holding active NDC listings and approved CAGE codes 1LZX9 or 3LDD7, ensuring strict federal compliance and integration into prime contract deliverables. This procurement is tightly regulated to maintain quality and regulatory standards within the Defense Logistics Agency’s supply chain, with all products required to meet mandated criteria for use in medical and surgical settings under Department of Defense requirements. The solicitation, classified as a subcontract under NAICS code 325411, is managed by the Defense Logistics Agency and was posted on July 17, 2026. While no specific place of performance or point of contact is provided, the contract is linked to prime contract deliverables and is accessible through the DIBBS system under contract SPE2DX25D9900 and delivery order SPE2DP26F7735, emphasizing its role in supporting federal medical logistics operations.

Defense Logistics Agency

POSTED

DEADLINE

Bulk Active Pharmaceutical Ingredient (API) SupplyThe contract entails the supply of bulk pseudoephedrine hydrochloride active pharmaceutical ingredient for use in the manufacturing of tablet formulations, with strict adherence to U.S. Food and Drug Administration and Drug Enforcement Administration regulations to ensure quality, security, and compliance with controlled substance standards. The agreement is structured as a subcontract under the Defense Logistics Agency, part of the Department of Defense, and falls under the NAICS code 325411 for pharmaceutical and biological product manufacturing. The supply must meet all federal requirements for handling, documentation, and tracking of this regulated substance, including chain-of-custody protocols and production controls. Performance is expected to support national pharmaceutical needs without specified geographic limitations, and the contract is linked to a specific procurement identifier under the DIBBS system, indicating formal award and tracking through official defense logistics channels.

Defense Logistics Agency

POSTED

DEADLINE

SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100 mg, are specified for acute treatment of migraine with or without aura in adults, packaged in bottles of nine tablets each, with a total quantity of four bottles required under this contract. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, with a non-extendable shelf life of 24 months as mandated by RS016 and RS001 for TYPE I (CODE M) items. Packaging and marking must comply with MIL-STD-2073-1E, MIL-STD-129, and the latest Medical Marking Standard No. 1, including DLA-specific packaging requirements, and palletization must adhere to RP001 guidelines. The item is regulated by the FDA, and bidders must provide detailed manufacturer and product information for verification, including NDC numbers NDC00378-5632-59 and NDC51407-0013-09 from Mylan Pharmaceuticals Inc and Golden State Medical Supply, Inc. Delivery is required FOB destination within 20 days, with no variance in quantity accepted, and shipment must be sent by the fastest traceable means, excluding parcel post. The delivery and shipping address is Fort Stewart, Georgia, with the required delivery date set for July 17, 2026, under solicitation SPE2DP-26-T-4166, and all technical and quality requirements referenced in the DLA Master List are binding.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 10 hours

NIRMATRELVIR AND RIPaxlovid, containing nirmatrelvir and ritonavir tablets, is being procured under a government contract requiring 50 boxes, each containing 10 blister cards with three tablets per card—two 150 mg nirmatrelvir tablets and one 100 mg ritonavir tablet—providing a five-day supply at two daily doses per box. The product is manufactured by Pfizer Inc with NDC 00069-5321-30 and is regulated by the FDA, requiring confirmation through an EBS referral. Each box is a unit of issue, and the item has a fixed 36-month shelf life that cannot be extended, in compliance with TYPE I (CODE Q) standards. Packaging must meet MIL-STD-2073-1E and the Medical Marking Standard No. 1, superseding MIL-STD-129, with all units sealed in commercial containers to ensure safe transport and delivery. Shipment must be delivered FOB destination within 20 days to the Navy Expeditionary Central Facility in Williamsburg, VA, using the fastest traceable means, excluding parcel post, and must be palletized according to DLA packaging requirements. The contract includes strict quality and technical specifications referenced from the DLA Master List, with no variance allowed in quantity and inspection and acceptance occurring at the delivery point. The solicitation number is SPE2DP-26-T-4168, with a response deadline of July 22, 2026, and an original required delivery date of April 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

in about 21 hours

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

SODIUM CHLORIDE INJECTSodium Chloride 0.9% Injection, USP, in 250 mL bags, is being procured under contract SPE2DP-26-T-4215 with a requirement for two packaging groups, each containing 24 bags, for a total of 48 units. The product must comply with the DLA Master List of Technical and Quality Requirements, including Medical Marking Standard No. 1, which replaces all prior references to MIL-STD-129, and all packaging must be commercial grade, sealed, and designed to protect against damage during transport. Each unit must be packed in suitable shipping containers that ensure safe delivery via common carrier to the designated destination at the lowest possible freight cost. The item is regulated by the FDA, and procurement requires confirmation through EBS referral to the product specialist, including manufacturer and part number details. The product has a fixed 24-month shelf life with no extensions allowed, and must be stored at room temperature (25°C), with brief exposure to temperatures up to 40°C permitted without degradation. Approved manufacturers include B. Braun Medical Inc., ICU Medical, Inc., Cardinal Health 200, LLC, Owens & Minor Distribution Inc., and Trillamed LLC, each with specified NDC and part numbers. Delivery is required FOB destination within 20 days, with no tolerance for quantity variance. Inspection and acceptance occur at the delivery point, and the item is identified by NSN 6505-01-331-8945 under a federal solicitation issued by the Department of Defense’s Medical Supply Chain PHARM FSA.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

PENTOBARBITAL SODIUPentobarbital Sodium Injection, Veterinary, is a Schedule II controlled substance with high abuse potential, manufactured as a 250 mL vial containing six grains of sodium pentobarbital for euthanasia purposes. The product is regulated by the FDA and subject to stringent federal controls, requiring storage in a vault at room temperature due to its classification as a DEA C-II drug. It must be labeled and packaged in accordance with the latest Medical Marking Standard No. 1 and DLA Packaging Requirements, with no tolerance for quantity variance—exactly two units are contracted for delivery within 89 days FOB destination, inspected and accepted at the delivery point. The item carries a non-extendable 24-month shelf life and must comply with OSHA’s Hazard Communication Standard, including submission of approved Safety Data Sheets and GHS-compliant labels prior to contract award. Suppliers are required to ensure employee training on hazardous communication protocols under 29 C.F.R. 1910.1200 and must remove all government identification from non-accepted items. This procurement is governed under solicitation SPE2DP-26-T-4219, with primary point of contact at the Department of Defense’s Medical Supply Chain, and delivery addressed to APO 96260-5479.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

LIDOCAINE HYDROCHLOLidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable pharmaceutical product containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL single-dose cartridges. The unit of issue is a package of 50 cartridges, each contained within cardboard boxes featuring five blisters of ten cartridges each. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is regulated by the FDA and requires a prescription. The item has a non-extendable shelf life of 18 months and must be marked in full compliance with Medical Marking Standard No. 1, superseding all prior references to MIL-STD-129. Packaging and shipping must meet commercial standards, with each unit sealed and protected in suitable containers to ensure safe transport via common carrier, and all exterior containers must meet federal logistics requirements. The procurement is issued under contract SPE2DP-26-T-4213 with a solicitation posted on July 21, 2026, and responses due by July 27, 2026. The quantity required is one unit of issue (50 cartridges), with delivery required within five days of award to the destination at Joint Base Elmendorf-Richardson, Alaska. Delivery is FOB destination and subject to zero variance in quantity. Inspection and acceptance occur upon delivery. The item is classified under NSN 6505-01-576-2767, with procurement reference PR 7017548713. All technical and quality requirements referenced in the DLA Master List are incorporated by reference, and the product must be sourced from approved manufacturers including Dentsply Sirona Inc. with NDC 66312-0181-16. Government use requires adherence to all applicable defense logistics standards, including transport protocols and marking instructions, with a designated point of contact and official delivery address provided for coordination.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 14 hours ago

DEADLINE

PERMETHRIN CREAM RINSEPermethrin Cream Rinse is a 1% w/v topical pharmaceutical product supplied in plastic squeeze bottles containing 2 fluid ounces, each accompanied by a comb for application. The item is regulated by the FDA and must be received with a minimum of 21 months of remaining shelf life from the date of delivery, with a total shelf life of 24 months. Packaging must comply with commercial standards and medical marking standard No. 1, superseding all prior references to MIL-STD-129, ensuring protection against damage and safe transport via common carriers. Each unit must be sealed in an appropriate container and packed in suitable shipping containers to guarantee secure delivery to the designated FPO address. The product is classified as a hazardous material, requiring submission of current Safety Data Sheets (SDS) consistent with OSHA’s revised Hazard Communication Standard, which replaced MSDS requirements as of June 1, 2015. SDS must be provided to the contracting officer for approval prior to award and must accompany each shipment. Labels must conform to GHS and relevant federal regulations under 29 C.F.R. 1910.1200. Packaging must meet 49 CFR and ICAO standards for hazardous materials transport. The item is identified by NSN 6505-01-256-4972, with a purchase request of 2 units and a delivery deadline of 20 days after order award. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with applicable references RA001, RP001, and RQ001, and the procurement is issued under solicitation SPE2DP-26-T-4223 by the Department of Defense’s Medical Supply Chain PHARM FSA.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

SODIUM CHLORIDE INJECTSodium Chloride Injection 0.9% in 100 mL fill plastic containers, packaged in lots of 64 units per purchase group, is being procured under contract SPE2DP-26-T-4218 with a delivery requirement of 20 days FOB destination. The item is manufactured by B. Braun Medical Inc. with NDC 00264-1800-32 and part number S8004-5264, and is identified by NSN 6505-01-330-8924. The product has a non-extendable shelf life of 15 months and must be stored at room temperature, avoiding excessive heat. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must include the NSN, manufacturer, Cage code, date of manufacture, expiration or retest date, contract number, and lot number. Each unit must be sealed in a protective container, and shipments must use commercial exterior packaging suitable for safe transport by common carrier at the lowest cost. The contract specifies zero variance in quantity and requires inspection and acceptance at the destination. This is a regulated medical product under FDA oversight, and the contracting official must submit a referral in EBS for confirmation prior to award. The solicitation was posted on July 21, 2026, with a response deadline of July 27, 2026, and performance is directed to Fort Campbell, 42223-5000.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

BISMUTH SUBSALICYLATEBismuth subsalicylate tablets are being procured under a military contract with each tablet containing 262 mg of active ingredient and 140 mg of calcium, formulated as sugar-free oral tablets. The unit of issue is a single package containing 48 individually sealed tablets, with a total shelf life of 36 months and a mandatory minimum of 31 months remaining at the time of receipt by the first government activity. Packaging must comply with commercial standards and the Medical Marking Standard No. 1A dated February 4, 2013, ensuring product integrity and proper identification. Containers must protect against damage and breakage, and shipping containers must be suitable for safe delivery via common carrier at the lowest cost to the designated destination. The product is subject to strict temperature controls, avoiding exposure above 104°F or 40°C. The NSN is 6505012448010, with a procurement quantity of one package, delivery required within 20 days FOB destination, and no variance allowed in quantity. Inspection and acceptance occur at the destination. The contract is issued under Solicitation SPE2DP-26-T-4214, with a response deadline of July 27, 2026, and performance will be delivered to Fort Campbell, Kentucky. The supplier must be registered under either P/N NDC01490-0326-42 or NDC37000-0477-10, and all labeling, marking, and packaging must adhere to applicable DLA and DoD standards, including compliance with the DLA Master List of Technical and Quality Requirements incorporated by reference.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

BUPIVACAINE AND EPINEPThe contract specifies the procurement of bupivacaine and epinephrine injection in 1.8 mL cartridges containing 0.500 percent w/v bupivacaine HCl and 0.005 mg epinephrine per mL (1:200,000), packaged in units of 50 cartridges per carry case (CN). The product must be stored at controlled room temperature between 15 and 30 degrees Celsius with a shelf life of 18 months, ensuring at least 15 months of shelf life remains upon delivery to the first government activity. Packaging and labeling must comply fully with Medical Marking Standard No. 1, superseding MIL-STD-129, and all containers must be sealed and designed to prevent damage during transit. The material is subject to DLA Packaging Requirements and must be shipped using the fastest traceable means, prohibiting parcel post. Hazardous material regulations under Fed-STD-313 apply, requiring compliance with ASTM D3951 unless superseded by higher-priority DLA technical requirements. Mercury and mercury-containing compounds are strictly prohibited unless explicitly exempted for specific functional components. Delivery is FOB destination with zero quantity variance allowed, and the shipment must reach the specified FPO address within 20 days of contract award. The sole point of contact for inquiries is Nicholas Quigley of the Department of Defense’s Medical Supply Chain, and the procurement is governed under solicitation SPE2DP-26-T-4221 with an original required delivery date of July 23, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

about 14 hours ago

DEADLINE

SUNSCREEN PREPARATIONThis contract specifies the procurement of a topical sunscreen preparation containing 4.5% titanium dioxide and 4% zinc oxide with a sun protection factor (SPF) of 50, formulated to be sweat- and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, biodegradable, and suitable for outdoor use. The product is packaged in units of 24 three-ounce tubes per package, with a total shelf life of 24 months, and requires a minimum of 21 months of remaining shelf life upon receipt by the first government activity. Storage must be maintained between 15°C and 30°C (59°F and 86°F) in a cool, dry environment. The item is classified as a FDA-regulated medical product and must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging standards under Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercially sealed to protect against damage, and exterior shipping containers must ensure safe delivery at the lowest freight cost to the designated destination. The unit of issue is a package (PG), with a total quantity of four packages to be delivered FOB destination within 20 days. Delivery is directed to USS CHARLESTON LCS 18 at FPO AP 96694 via vessel shipment, using the fastest traceable means and prohibiting parcel post. The item is identified by NSN 6505-01-657-9247 and procurement request 7017560985, with a required delivery date of July 23, 2026. All packaging and labeling must conform to the latest edition of Medical Marking Standard No. 1 and DLA packaging requirements, and the material must be non-hazardous under FED-STD-313, complying with ASTM D3951 unless superseded by a higher-priority DLA technical requirement. The solicitation is issued under contract SPE2DP-26-T-4222, and bidders must confirm product specifications with the DLA product specialist through EBS, providing full manufacturer and item detail.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 14 hours ago

DEADLINE

Domestic and International Hazardous Materials Transportation CoordinationThe contract requires comprehensive coordination and management of hazardous medical materials transportation across domestic and international territories using air, ground, and sea modes, with strict adherence to federal and international regulations including 49 CFR, ICAO, IMDG, and DLAI 4145.3. A critical responsibility involves preparing accurate Shipper’s Declarations for military air shipments, ensuring all documentation meets stringent compliance standards for safety and legal requirements. The work is centered on maintaining seamless logistics while safeguarding personnel, infrastructure, and the environment throughout the transportation chain. Performance is mandated to occur in Groton, Connecticut, with a response deadline of July 27, 2026, and the contract is classified as a subcontract under NAICS code 484220. The awarding agency is the Department of Defense through the Medical Supply Chain Pharm FSA, indicating this effort supports critical military medical logistics operations. All activities must align with Defense Logistics Agency standards and ensure full traceability and regulatory control of hazardous shipments from origin to final destination.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Material Safety Data Sheet (MSDS) Management and DocumentationThe contract requires the preparation, updating, management, and submission of Material Safety Data Sheets for hazardous materials, ensuring strict adherence to OSHA, GHS, and DLA regulatory standards. All documentation must be maintained with a minimum three-year retention period to support compliance and audit readiness. The work is to be performed for the Department of Defense’s Medical Supply Chain Pharm FSA, with the place of performance located in Groton, Connecticut, at the zip code 06340-4905. This subcontract falls under NAICS code 541620, indicating it involves scientific and technical consulting services related to health and safety compliance. The solicitation was posted on July 20, 2026, with a response deadline of July 27, 2026, and additional information can be accessed through the DIBBS platform.

Environmental Consulting Services

POSTED

DEADLINE